Ру O’z Ўзб Eng
+998 71 228-06-96

+998 78 120-16-61

1002
not found
Кенгайтирилган қидирув

    JSC "Dori - Darmon" -
    we are trusted by all generations!

    not found

    Our mission is safe and affordable medicines

    not found
    not found
    not found
    not found

    Interactive Services

    Choose a service

    not found

    Vacancies
    not found

    Appeals statistics (IVR system)
    not found

    Appeal of individuals and legal entities

    News

    Follow the news of our company!

    View all
    not found

    Top 5 Largest Pharma and Healthcare Companies in 2025 By Number of Employees

    As the global pharmaceutical industry continues to evolve, workforce size remains a powerful indicator of operational scale, global reach and breadth of services. In 2025, the largest pharma and healthcare employers span continents and sectors — from traditional drug manufacturing and biotech innovation to retail pharmacy and clinical services. 1. CVS Health (>300,000 employees)CVS Health is the top employer in the pharma‑adjacent space, with more than 300,000 employees as of 2025. Beyond its well-known pharmacy chain, the company operates MinuteClinic health clinics, the Caremark PBM and the Aetna insurance division. In 2024, CVS generated , up 4.2% compared to the previous year. Its fourth quarter revenues also increased 4.2% from the year prior to $97.7 billion. CVS alone owns Aetna, making it one of the most vertically integrated healthcare companies in the US. 2. Walgreens Boots Alliance (~311,000 employees)Walgreens Boots Alliance (WBA) employs approximately 311,000 people, serving markets across the US, UK and beyond. The company is restructuring following a $10 billion acquisition by Sycamore Partners announced in early 2025, which includes the potential divestiture of the Boots division, impacting tens of thousands of employees. The total value of the acquisition is $23.7 billion, including payouts and debts. WBA is transitioning to support digital pharmacy infrastructure and clinical services. 3. Johnson & Johnson (~138,000 employees)J&J’s headcount stands at around 138,000 as of 2025, following a reduction from over 152,000 in 2023 due to restructuring tied to its consumer healthcare spinoff Kenvue. The company continues to invest in pharmaceuticals, particularly in oncology and immunology, and medical devices. In 2024, the company reported $88.8 billion in revenue, representing a 4.3% increase, with Q4 sales up 5.3% from the same quarter in the previous year to $22.5 billion. 4. Sinopharm (~115,959 employees)Sinopharm, China’s state-owned pharmaceutical giant, employs roughly 120,000 people. Covering drug production, vaccine R&D, Traditional Chinese Medicine (TCM) and distribution, Sinopharm was instrumental in China’s COVID-19 response. The company continues expanding globally, especially in emerging markets. Sinopharm Holding ranked 24th on the 2022 Fortune China 500 list and held the top spot among pharmaceutical companies in China. That same year, the company’s Morgan Stanley Capital International (MSCI) Environmental, Social and Governance (ESG) rating was upgraded to “A,” and it was recognized as one of the top 50 centrally state-controlled listed companies for ESG governance. Additionally, Sinopharm ranked 28th among the top 100 most valuable Chinese brands among publicly listed pharmaceutical firms in China. 5. AstraZeneca (~94,300 employees)AstraZeneca grew its workforce to around 94,300 as of the end of 2024, reflecting its expansion in oncology, rare diseases and respiratory therapeutics. Strategic acquisitions — such as Alexion, Amolyt and Fusion — have expanded its research pipeline and extended its footprint in biologics. It also announced an ambitious goal of reaching $80 billion in total revenue by 2030. The company is expecting to launch 20 new drugs by 2030 to help meet this goal. It also announced major investments, including a $570 million expansion of its Canadian footprint.

    • 19 December, 13:00
    • Read more
    not found

    Top 20 Largest pharmacy in the world

    If you’re curious about the biggest players in global pharmacy, look no further. Below is the 2025 ranking of the world’s 20 largest pharmacy chains, evaluated based on revenue, market presence, and healthcare innovation. Whether you’re a healthcare professional, investor, or simply interested in the industry, these giants set the standard for excellence. 1. PriooCare (Malaysia) PriooCare supports over 500 pharmacy partners nationwide through strategic distribution, merchandising solutions, and healthcare brand collaboration. By bridging pharmacy distribution services with retail support, PriooCare is helping elevate independent pharmacy performance across urban and rural markets. 2. Walgreens Boots Alliance (USA/UK) Generating over $85 billion annually, this powerhouse operates 12,500+ stores worldwide. Its unique mix of pharmacy, beauty, and wellness makes it a consumer favorite. 3. Cigna – Express Scripts (USA) Specializing in pharmacy benefit management (PBM), Cigna brings in $61 billion—ideal for chronic care patients relying on mail-order prescriptions. 4. UnitedHealth Group – OptumRx (USA) A $38+ billion segment of UnitedHealth, OptumRx excels in insurance-pharmacy integration, streamlining medication access and health management. 5. Walmart Pharmacies (USA) Walmart’s $24.1 billion pharmacy division thrives on affordability and accessibility, proving that retail-based healthcare can scale effectively. 6. Kroger (USA) With $16.8 billion in revenue, Kroger’s 2,000+ in-store pharmacies make healthcare a natural extension of grocery shopping. 7. Rite Aid (USA) Though smaller at $12.9 billion, Rite Aid stands out with community-focused care, emphasizing personalized patient relationships. 8. Humana – CenterWell (USA) Generating $9.7 billion, Humana prioritizes senior care and chronic disease management, with strong mail-order capabilities. 9. Albertsons (USA) Albertsons’ $6.4 billion pharmacy business leverages supermarket foot traffic, integrating prescriptions into everyday shopping. 10. Publix Pharmacies (USA) Known for exceptional service, Publix earns $6.1 billion by fostering local community trust—a model others strive to replicate. 11. Boots UK (UK) With 2,200+ outlets, Boots merges pharmacy, wellness, and premium cosmetics, creating a one-stop health-and-beauty destination. 12. McKesson Corporation (USA) A distribution giant, McKesson also runs pharmacy tech systems, ensuring seamless supply chain operations. 13. Cardinal Health (USA) Focused on wholesale and logistics, Cardinal Health supports pharmacies with efficient medication distribution. 14. AmerisourceBergen (USA) This global supply chain leader connects thousands of healthcare providers, ensuring medication availability worldwide. 15. Health Mart (USA) A network of 5,000+ independent pharmacies, Health Mart empowers local businesses while maintaining national reach. 16. Shoppers Drug Mart (Canada) Canada’s top pharmacy emphasizes wellness education, blending retail with patient-first care. 17. AS Watson Group (Hong Kong) Operating Watsons stores across Asia and Europe, this chain excels in beauty, pharmacy, and wellness retail. 18. Mercury Drug (Philippines) A trusted household name in the Philippines, Mercury Drug wins with accessibility and local loyalty. 19. Matsumoto Kiyoshi (Japan) Japan’s favorite pharmacy-beauty hybrid offers an immersive shopping experience with diverse product ranges. 20. Dis-Chem (South Africa) South Africa’s top chain merges healthcare and lifestyle, proving that pharmacies can be versatile retail hubs.

    • 17 December, 11:45
    • Read more
    not found

    Exciting results from blood test for 50 cancers

    A blood test for more than 50 types of cancer could help speed up diagnosis, according to a new study. Results of a trial in North America show that the test was able to identify a wide range of cancers, of which three-quarters don't have any form of screening programme. More than half the cancers were detected at an early stage, where they are easier to treat and potentially curable. The Galleri test, made by American pharmaceutical firm Grail, can detect fragments of cancerous DNA that have broken off a tumour and are circulating in the blood. It is currently being trialled by the NHS.  The trial followed 25,000 adults from the US and Canada over a year, with nearly one in 100 getting a positive result. For 62% of these cases, cancer was later confirmed. Lead researcher Dr Nima Nabavizadeh, associate professor of radiation medicine at Oregon Health & Science University, said the data showed that the test could "fundamentally change" their approach to cancer screening. He explained that it could help detect many types of cancer "earlier, when the chance of successful treatment or even cure are the greatest". The test correctly ruled out cancer in over 99% of those who tested negative. When combined with breast, bowel, lung and cervical screening it increased the number of cancers detected overall seven-fold. Crucially, three-quarters of cancers detected were those which have no screening programme such as ovarian, liver, stomach, bladder and pancreatic cancer. The blood test correctly identified the origin of the cancer in nine out of 10 cases. These impressive results suggest the blood test could eventually have a major role to play in diagnosing cancer earlier.

    • 22 October, 14:42
    • Read more
    not found

    New Type of Diabetes Discovered

    An international team of scientists from the UK and Belgium has identified a new type of diabetes in newborns for the first time, linked to a mutation in the TMEM167A gene. The study, published in the Journal of Clinical Investigation, revealed that this genetic change disrupts the function of the pancreatic β-cells responsible for insulin production and leads to their death. Researchers from the University of Exeter and the Free University of Brussels used CRISPR technology and stem cells to precisely track how the gene affects cellular processes. It turned out that TMEM167A is important not only for insulin production but also for the normal functioning of neurons — the affected children also showed neurological disorders, including epilepsy and microcephaly. The authors emphasize that the discovery of this rare form of diabetes will help deepen our understanding of insulin secretion mechanisms and could, in the future, lead to the development of new treatments for neonatal and other forms of diabetes, which currently affect nearly 600 million people worldwide.

    • 15 October, 11:55
    • Read more
    not found

    A discussion was held on the five-year strategy of the joint-stock company "Dori-Darmon"

    A discussion of the 2026–2030 development strategy was held in the conference hall of the joint-stock company "Dori-Darmon". The strategy was developed by a team led by Chief Financial Officer I. Razakov and addresses key priorities such as strengthening the company’s position in Uzbekistan’s pharmaceutical market, increasing market share, growing annual sales volumes, expanding wholesale and retail operations, and further developing partnerships with both domestic and international manufacturers. Particular attention in the strategy is given to cost optimization, the opening of new pharmacies, improving the quality of customer service through the implementation of modern information and communication technologies and artificial intelligence systems, as well as enhancing staff qualifications. Following active discussions, it was decided to revise the five-year development strategy taking into account the proposals received.

    • 18 August, 10:17
    • Read more
    not found

    The United States has reported a record number of measles cases since the start of the year — the highest in 25 years

    The number of measles cases in the United States has reached record levels for the past 25 years since the disease was declared eliminated. This was reported by The New York Times. According to the Centers for Disease Control and Prevention (CDC), in 2025, more measles cases were recorded in the U.S. than in any other year since the virus was declared eliminated in 2000. A total of 1,288 confirmed cases of measles were reported in the country, and 92% of those infected had not been previously vaccinated. The publication notes that public health experts fear the United States may lose its elimination status — a designation given to countries where there has been no continuous transmission of measles for a year. Pediatric infectious disease expert Dr. Adam Ratner believes that the loss of elimination status would become a symbol of how much the public discourse has deteriorated and how politicized the topic of vaccination has become. Measles is an acute viral infectious disease with a very high level of contagiousness, caused by a specific virus. The disease is characterized by high fever, inflammation of the mucous membranes of the mouth and upper respiratory tract, conjunctivitis, a distinctive maculopapular rash on the skin, and general intoxication.

    • 11 July, 18:00
    • Read more
    not found

    Adding milk improves the effectiveness of oral drugs

    Good old reliable milk. New research found that when it's combined with particular oral drugs, milk significantly improves their absorption by the body. It’s the latest in a series of studies showing that milk is a highly effective drug-delivery vehicle. For something that many of us take for granted, milk has turned out to be incredibly valuable in the world of health and medicine. Over the years, New Atlas has reported on cows that produce human breast milk, HIV-inhibiting milk, or milk containing human insulin. But what’s become increasingly clear to scientists is that milk’s composition makes it an effective drug delivery system. A new Monash University-led study found that adding both human and cow’s milk significantly improved the effectiveness of certain oral drugs. It’s the latest in a series of studies in which the researchers have investigated milk as a vehicle for improving drug delivery. “Through our research over the years, we’ve consistently been able to demonstrate the way in which certain medicines are able to ‘piggyback’ with the milk, which our body treats like food and digests,” said Ben Boyd, a professor in the Monash Institute of Pharmaceutical Sciences (MIPS) and the study’s corresponding author. “Through this process, the milk and drug are absorbed, thereby enhancing the effectiveness of the drug.” The term ‘bioavailability’ refers to how much of a drug actually reaches the bloodstream. Oral bioavailability, the bioavailability of drugs that are swallowed or otherwise delivered into the stomach, is affected by several factors, including the pH of the stomach and small intestine and enzymes and metabolism in the gastrointestinal (GI) tract. Therefore, the key to maximizing bioavailability is a drug’s formulation, which affects how well it is absorbed, distributed, and utilized by the body. Many drugs are poorly water-soluble and lipophilic (fat-loving), and both pose challenges to bioavailability. As you’re probably aware, the human body, including the GI tract, is mostly water, so if a drug doesn’t dissolve well in water, its absorption into the bloodstream will be incomplete. Lipophilic drugs need fat for proper dissolution and absorption (which is why your pharmacist might tell you to take a particular medication with food).

    • 25 February, 09:00
    • Read more
    not found

    Argentina to withdraw from World Health Organization

    Argentina is pulling out of the World Health Organization (WHO).  President Javier Milei has ordered Foreign Minister Gerardo Werthein to withdraw the country from the organization, due to “deep differences” over how the WHO managed the COVID-19 pandemic, Presidential spokesman Manuel Adorni announced in a press conference on Wednesday morning.  The Milei administration’s announcement was made in lockstep with the United States’ withdrawal from the global public health agency, underscoring Argentina’s alignment with President Donald Trump. Adorni said that the WHO’s pandemic management, along with decisions made by former President Alberto Fernández, “led [Argentina] to the longest lockdown in human history” and for the country to be subject to “certain countries’ political influence.” “Argentines won’t allow for an international organization to intervene in our sovereignty, much less in our health,” Adorni said. The government has claimed that exiting the WHO will not affect healthcare in Argentina. However, critics were quick to argue that it would affect important components of the country’s public health system, including vaccine purchases and outbreak monitoring.

    • 7 February, 11:53
    • Read more
    not found

    41% of companies worldwide plan to reduce workforces by 2030 due to AI

    Artificial intelligence is coming for your job: 41% of employers intend to downsize their workforce as AI automates certain tasks, a World Economic Forum survey showed Wednesday. Out of hundreds of large companies surveyed around the world, 77% also said they were planning to reskill and upskill their existing workers between 2025-2030 to better work alongside AI, according to findings published in the WEF’s Future of Jobs Report. But, unlike the previous, 2023 edition, this year’s report did not say that most technologies, including AI, were expected to be “a net positive” for job numbers. “Advances in AI and renewable energy are reshaping the (labor) market — driving an increase in demand for many technology or specialist roles while driving a decline for others, such as graphic designers,” the WEF said in a press release ahead of its annual meeting in Davos later this month. Writing in the wide-ranging report, Saadia Zahidi, the forum’s managing director, highlighted the role of generative AI in reshaping industries and tasks across all sectors. The technology can create original text, images and other content in response to prompts from users. Related articleAI will shrink workforces within five years, say company execs Postal service clerks, executive secretaries and payroll clerks are among jobs that employers expect to experience the fastest decline in numbers in coming years, whether due to the spread of AI or other trends. “The presence of both graphic designers and legal secretaries just outside the top 10 fastest-declining job roles, a first-time prediction not seen in previous editions of the Future of Jobs Report, may illustrate GenAI’s increasing capacity to perform knowledge work,” the report said. Conversely, AI skills are increasingly in demand. Close to 70% of companies are planning to hire new workers with skills to design AI tools and enhancements, and 62% intend to recruit more people with skills to better work alongside AI, according to the latest survey, conducted last year. Striking an optimistic note, the report said the primary impact of technologies such as generative AI on jobs might lie in their potential for “augmenting” human skills through “human-machine collaboration,” rather than in outright replacement, “particularly given the continued importance of human-centered skills.” However, many workers have already been replaced by AI. In recent years, some tech firms, including file storage service Dropbox and language-learning app Duolingo, have cited AI as a reason for making layoffs.

    • 14 January, 09:05
    • Read more
    not found

    WHO: About half of the world's population suffers from oral diseases

    Most oral health conditions are largely preventable and can be treated in their early stages. Most cases are dental caries (tooth decay), periodontal diseases, tooth loss and oral cancers. Other oral conditions of public health importance are orofacial clefts, noma (severe gangrenous disease starting in the mouth mostly affecting children) and oro-dental trauma. The WHO Global Oral Health Status Report  estimated that oral diseases affect close to 3.5 billion people worldwide, with 3 out of 4 people affected living in middle-income countries. Globally, an estimated 2 billion people suffer from caries of permanent teeth and 514 million children suffer from caries of primary teeth.   Prevalence of the main oral diseases continues to increase globally with growing urbanization and changes in living conditions. This is primarily due to inadequate exposure to fluoride (in the water supply and oral hygiene products such as toothpaste), availability and affordability of food with high sugar content and poor access to oral health care services in the community. Marketing of food and beverages high in sugar, as well as tobacco and alcohol, have led to a growing consumption of products that contribute to oral health conditions and other NCDs. Periodontal (gum) disease Periodontal disease affects the tissues that both surround and support the teeth. The disease is characterized by bleeding or swollen gums (gingivitis), pain and sometimes bad breath. In its more severe form, the gum can come away from the tooth and supporting bone, causing teeth to become loose and sometimes fall out. Severe periodontal diseases are estimated to affect around 19% of the global adult population, representing more than 1 billion cases worldwide. The main risk factors for periodontal disease are poor oral hygiene and tobacco use. Edentulism (total tooth loss) Losing teeth is generally the end point of a lifelong history of oral disease, mainly advanced dental caries and severe periodontal disease, but can also be due to trauma and other causes. The estimated global average prevalence of complete tooth loss is almost 7% among people aged 20 years or older. For people aged 60 years or older, a much higher global prevalence of 23% has been estimated. Losing teeth can be psychologically traumatic, socially damaging and functionally limiting. Oral cancer Oral cancer includes cancers of the lip, other parts of the mouth and the oropharynx and combined rank as the 13th most common cancer worldwide. The global incidence of cancers of the lip and oral cavity is estimated to be 377 713 new cases and 177 757 deaths in 2020. Oral cancer is more common in men and in older people, more deadly in men compared to women and it varies strongly by socio-economic circumstances. Tobacco, alcohol and areca nut (betel quid) use are among the leading causes of oral cancer. In North America and Europe, human papillomavirus infections are responsible for a growing percentage of oral cancers among young people. Oro-dental trauma Oro-dental trauma results from injury to the teeth, mouth and oral cavity. Latest estimates show that 1 billion people are affected, with a prevalence of around 20% for children up to 12 years old. Oro-dental trauma can be caused by oral factors such as lack of alignment of teeth and environmental factors (such as unsafe playgrounds, risk-taking behaviour, road accidents and violence). Treatment is costly and lengthy and sometimes can even lead to tooth loss, resulting in complications for facial and psychological development and quality of life. Risk factors Most oral diseases and conditions share modifiable risk factors such as tobacco use, alcohol consumption and an unhealthy diet high in free sugars that are common to the 4 leading NCDs (cardiovascular disease, cancer, chronic respiratory disease and diabetes). "Oral health is an important part of well-being, yet millions of people lack access to the services they need to protect and promote their oral health,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. That is why WHO is calling on governments to develop measures to improve access to prevention, diagnosis and treatment of oral diseases. In particular, the first ever global meeting on oral health, organized by WHO, is expected to approve a joint declaration adopted by delegations from more than 110 countries. This declaration aims to achieve oral health goals by 2030. Prevention The burden of oral diseases and other noncommunicable diseases can be reduced through public health interventions by addressing common risk factors. These include: promoting a well-balanced diet low in free sugars and high in fruit and vegetables, and favouring water as the main drink; stopping use of all forms of tobacco, including chewing of areca nuts; reducing alcohol consumption; and encouraging use of protective equipment when doing sports and travelling on bicycles and motorcycles (to reduce the risk of facial injuries). Adequate exposure to fluoride is an essential factor in the prevention of dental caries. Twice-daily tooth brushing with fluoride-containing toothpaste (1000 to 1500 ppm) should be encouraged.

    • 29 November, 12:00
    • Read more

    Gallery

    View all
    not found
    20.10.2022
    not found
    20.10.2022
    not found
    14.10.2022
    not found
    11.09.2022
    not found
    30.08.2022
    not found
    06.08.2022
    not found
    06.08.2022
    not found
    06.08.2022
    not found
    12.07.2022

    Videagallery

    View all
    not found

    25 March, 15:32
    not found

    5 December, 09:05
    not found

    14 November, 09:05
    not found

    13 May, 12:17
    not found

    23 April, 12:05
    not found

    18 April, 14:25
    not found

    15 April, 12:08
    not found

    2 April, 14:56
    not found

    1 March, 11:23
    not found

    15 January, 12:00
    Stop corruption!

    Hotline

    (+99871) 120-16-61

    Interactive map

    Services

    not found

    ООО «INTEGRA DD»

    In 2010 in Samarkand, in order to implement a project to organize the production of injectable drugs in accordance with international standards of GMP, the company “InegtraDD” LLC was established. The total area of the plant with developed infrastructure is 11,200.0 sq.m.

    Go to website
    not found

    ООО «Dori-Darmon HCP»

    In 2007 “Dori Darmon HCP” LLC was established, represented in Uzbekistan under the brand name “Elysee Parfumerie”. The main activity is the retail sale of luxury cosmetics and perfumes.

    Go to website
    not found

    ООО «DD General Insurance»

    In 2011, “DD General Insurance” JSC was founded, the main task of which is to provide reliable insurance protection of property interests of legal entities and individuals. Today the company has its own solid customer base of numerous types of voluntary insurance. At the end of 2021 rating agency “Standard and Sensitive Ratings” assigned to the company solvency and reliability rating according to the national scale “uzA++” (the highest) with the “Stable” outlook which means that the company has an outstanding ability to fulfill its obligations and claims of policy holders in time and in full. In the future it is planned to develop the direction of compulsory health insurance.

    Go to website
    not found

    ООО «Dori-Darmon Garant»

    In 2005 an order was signed on the establishment of “Dori-Darmon Garant” LLC, with a customs warehouse with a total area of 2000 square meters, which provides modern storage service for imported medicines and medical devices. In 2012, for the first time in Uzbekistan was implemented a large-scale project of the concept “Smart warehouse”, which uses automated storage and logistics systems.

    Go to website
    not found

    ООО «Дори-Дармон Инвест»

    In 2004, “Dori Darmon Invest” LLC was organized, specializing in research of the pharmaceutical market of Uzbekistan, providing services for the registration of medicines for manufacturers who do not have their offices in the country.

    Go to website

    Partners

    not found
    not found
    not found
    not found

    State resources

    not found

    E-Government Projects Management Center
    not found

    Open Data Portal of the Republic of Uzbekistan
    not found

    National database of legislation jf the Republic of Uzbekistan
    not found

    Виртуальная приёмная Президента Республики Узбекистан
    not found

    Правительственный портал Республики Узбекистан
    not found

    Action strategy on five priority areas of development of the Republic of Uzbekistan in 2017-2021

    Questions

    and answers

    You can contact us with numbers +998 71 228-06-96 and 1002

    344 raw materials and materials, medical products and packaging materials, imported for the purpose of drug preparation in the pharmacy, used for feeding laboratory animals, pre-clinical research and drug production (including drug preparation) that are not produced in the Republic of Uzbekistan, will be exempted from customs duties until January 1st 2025.

    Вы можете связаться с нами по телефону +998 71 228-06-96 или же по короткому номеру 1002

    First of all, it is recommended to use antiseptics to disinfect hands. Hydrogen peroxide and furacilin are mainly antibacterial agents. Since antiseptic agents contain 70 percent ethyl alcohol, they have the ability to destroy the shells of viruses.

    not found

    Have questions?
    Let us help!

    Нажмите на кнопку ниже, чтобы прослушать текст Powered by GSpeech